Thomas E. Mabry

1.1k citations

13 papers · 185 indexed · h-index 9

Impact in

Hepatology
Computational Theory and Mathematics
- Computational Drug Discovery Methods

Papers in

Virology 1
- HIV Research and Treatment 1
Pharmacology 3

Co-authors: C. David Jones Joseph M. Colacino Kirk A. Staschke James E. Audia Patrick C. May Jeffrey S. Nissen Larry C. Blaszczak Mark H. Bender
Journals: Neurobiology of Aging (3 papers)Journal of Medicinal Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)The Journal of Clinical Pharmacology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
Partner nations: United States

In The Last Decade

Thomas E. Mabry

12 papers receiving 185 citations

Peers

Countries citing papers authored by Thomas E. Mabry

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Mabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Mabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Mabry more than expected).

Fields of papers citing papers by Thomas E. Mabry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Mabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Mabry. The network helps show where Thomas E. Mabry may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas E. Mabry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas E. Mabry Line = papers co-authored together Thomas E. Mabry links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Field efficacy, adult emergence, and yield evaluation of the corn rootworm transgenic events in Vorceed™ Enlist® corn and SmartStax® PRO hybrid corn against corn rootworms (Coleoptera: Chrysomelidae) Crop Protection ·Thomas E. Mabry, Pranita Sharma, R. B. Weir, T. M. Nowatzki, James Bing, Amit Sethi, A Voinov, K. J. Kim	2025	0
2	Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet–Induced Obese Rats Journal of Pharmacology and Experimental Therapeutics ·Thomas Estridge, Asim Dey, Charles A. Reidy, ERIC H. BEVERSLUIS, Yuke Zhang, GwanSeon Kim, Dexter Mk, Najia Jin, Mark C. Kowala, Jennifer Leohr, Adrian J. Fretland, Thomas E. Mabry, Debra Luffer‐Atlas, Mengdie Luo	2017	4
3	Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase‐1 The Journal of Clinical Pharmacology ·Jennifer Leohr, Debra Luffer‐Atlas, Mengdie Luo, David J. DeBrota, Colin Green, Thomas E. Mabry, Jeffrey G. Suico	2017	2
4	Glucocorticoid Receptor Modulators Informed by Crystallography Lead to a New Rationale for Receptor Selectivity, Function, and Implications for Structure-Based Design Journal of Medicinal Chemistry ·Matthew W. Carson, J.G. Luz, Chen S. Suen, Chahrzad Montrose, Richard W. Zink, Xiaoping Ruan, Christine C. Cheng, Harlan W. Cole, Mary D. Adrian, M. Hussain, Thomas E. Mabry, Nancy Snyder, Zhongliang Yao, Knut Egeröd, David K. Clawson, Anna Pustilnik, Michael J. Coghlan	2014	25
5	P1-180 Reduction in a-beta(1-40) and A-beta(1-42) in CSF and plasma in the beagle dog following acute oral dosing of the gamma secretase inhibitor, LY450139 Neurobiology of Aging ·Paul A. Hyslop, Patrick C. May, James E. Audia, David O. Calligaro, Carl L. McMillian, Gelder L. Van, Jeffrey W. Cramer, Bruce D. Gitter, Warren J. Porter, M. Olaizola, Thomas E. Mabry, Mark H. Bender	2004	12
6	P4-339 Stereoselective inhibition of amyloid beta peptide secretion by LY450139, a novel functional gamma secretase inhibitor Neurobiology of Aging ·Bruce D. Gitter, Dan L. Czilli, Weiying Li, Mazhirina K.G., Mark H. Bender, Jeffrey S. Nissen, Thomas E. Mabry, Tinggui Yin, Leonard N. Boggs, Don B. McClure, Sheila P. Little, Edward M. Johnstone, James E. Audia, Patrick C. May, Paul A. Hyslop	2004	21
7	P1-419 In vivo characterization of LY450139, a novel, stereoselective, functional gamma-secretase inhibitor Neurobiology of Aging ·Leonard N. Boggs, Kimberly S. Fuson, Bruce D. Gitter, Makhrosh Zulu, Paul A. Hyslop, Mark H. Bender, Weiying Li, James E. Audia, Jeffrey S. Nissen, Thomas E. Mabry, Binhui Ni, Yuan Su, Patrick C. May	2004	12
8	A series of C-Terminal amino alcohol dipeptide Aβ inhibitors Bioorganic & Medicinal Chemistry Letters ·Albert W. Garofalo, Intlekofer in Kork in Baden, Yujie Wei, James E. Audia, Poojashree Hebbar, Harry F. Dovey, M. Bucciolini, Zuzana Janovská, Erich Goldbach, Yao Jing-dong, Lee H. Latimer, Thomas E. Mabry, Jeffrey S. Nissen, Michael A. Pleiss, I. Sopivnyk, Eugene D. Thorsett, Jay S. Tung, Jing Wu	2002	17
9	The in vitro anti-hepatitis B virus activity of FIAU [1-(2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell Antiviral Research ·Kirk A. Staschke, Joseph M. Colacino, Thomas E. Mabry, C. David Jones	1994	34
10	Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers Antimicrobial Agents and Chemotherapy ·Ronald R. Bowsher, S. Fuchs, José Heredia Maya, Martin Wördenweber, C. David Jones, Thomas E. Mabry, David L. Hyslop, 曾明安, K A DeSante	1994	20
11	Synthesis of 4-Amino-8-(2, 2-Difluoro-2-Deoxy-β-D-Ribo Furanosyl Amino)Pyrimido [5, 4-D]Pyrimidine (dFARPP). Stability and Cellular Cytotoxicity Nucleosides and Nucleotides ·Thomas E. Mabry, C. David Jones, Tse‐Chuan Chou, Joseph M. Colacino, Gerald B. Grindey, John F. Worzalla, Homer L. Pearce	1994	13
12	Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogs of trioxifene, [3,4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl[methanone Journal of Medicinal Chemistry ·Charles D. Jones, Larry C. Blaszczak, Mark S. Goettel, Zheng Zhang, Thomas A. Crowell, Thomas E. Mabry, Peter C. Ruenitz, You Wu	1992	23
13	The synthesis of the ²H, ³H, and ¹⁴C‐isotopomers of 2′‐deoxy‐2′,2′‐difluorocytidine hydrochloride, an anti‐tumor compound Journal of Labelled Compounds and Radiopharmaceuticals ·William J. Wheeler, Thomas E. Mabry, C. David Jones	1991	2

About Thomas E. Mabry

Thomas E. Mabry is a scholar working on Virology, Pharmacology, Computational Theory and Mathematics, Molecular Biology and Oncology, having authored 13 papers that have together received 185 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (2 papers), Computational Drug Discovery Methods (2 papers), Cancer therapeutics and mechanisms (2 papers), Estrogen and related hormone effects (2 papers), Chemical Synthesis and Analysis (1 paper), HIV Research and Treatment (1 paper), Synthesis and biological activity (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Hepatology (20 citations), Computational Theory and Mathematics (35 citations), Pharmacology (18 citations), Pharmacology (34 citations) and Physiology (48 citations). Thomas E. Mabry has collaborated with scholars based in United States. Frequent co-authors include C. David Jones, Joseph M. Colacino, Kirk A. Staschke, James E. Audia, Patrick C. May, Jeffrey S. Nissen, Larry C. Blaszczak, Mark H. Bender, Thomas A. Crowell and Paul A. Hyslop. Their work appears in journals such as Neurobiology of Aging, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, The Journal of Clinical Pharmacology and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact